Cargando…
First person – Geon Seong Lee
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Geon Seong Lee is first author on ‘ Morc2a p.S87L mutant mice develop peripheral and centra...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560495/ http://dx.doi.org/10.1242/dmm.049312 |
_version_ | 1784592939632033792 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Geon Seong Lee is first author on ‘ Morc2a p.S87L mutant mice develop peripheral and central neuropathies associated with neuronal DNA damage and apoptosis’, published in DMM. Geon Seong is a PhD student in the lab of Su Cheong Yeom at Seoul National University, Pyeongchang, South Korea, investigating gene-editing therapy for single-nucleotide polymorphism-mediated genetic disorder. |
format | Online Article Text |
id | pubmed-8560495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-85604952021-11-02 First person – Geon Seong Lee Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Geon Seong Lee is first author on ‘ Morc2a p.S87L mutant mice develop peripheral and central neuropathies associated with neuronal DNA damage and apoptosis’, published in DMM. Geon Seong is a PhD student in the lab of Su Cheong Yeom at Seoul National University, Pyeongchang, South Korea, investigating gene-editing therapy for single-nucleotide polymorphism-mediated genetic disorder. The Company of Biologists Ltd 2021-10-25 /pmc/articles/PMC8560495/ http://dx.doi.org/10.1242/dmm.049312 Text en © 2021. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Geon Seong Lee |
title | First person – Geon Seong Lee |
title_full | First person – Geon Seong Lee |
title_fullStr | First person – Geon Seong Lee |
title_full_unstemmed | First person – Geon Seong Lee |
title_short | First person – Geon Seong Lee |
title_sort | first person – geon seong lee |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560495/ http://dx.doi.org/10.1242/dmm.049312 |